Document is current
Any future updates will be listed below
-
Authors
Lee, Eunmi
Hong, Jason J. https://orcid.org/0000-0002-4631-131X
Samcam Vargas, Gabriel https://orcid.org/0009-0005-5353-1387
Sauerwald, Natalie
Wei, Yong https://orcid.org/0000-0002-1034-649X
Hang, Xiang
Theesfeld, Chandra L. https://orcid.org/0000-0002-8379-6600
Volmar, Jean Arly A.
Miller, Jennifer M.
Wang, Wei https://orcid.org/0000-0002-6558-4858
Wang, Sha
Laevsky, Gary
DeCoste, Christina J.
Kang, Yibin https://orcid.org/0000-0002-1626-6730
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA134519)
Ludwig Institute for Cancer Research
Breast Cancer Research Foundation
Susan G. Komen
American Cancer Society
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 9 May 2025
First Online: 25 May 2025
Competing interests
: Y.K. is a co-founder and chair of the Scientific Advisory Board of Firebrand Therapeutics, Inc. and Kayothera, Inc. The remaining authors declare no competing interests.
